403 related articles for article (PubMed ID: 2492341)
1. Differential inhibition by aspirin of platelet thromboxane and renal prostaglandins in the rat.
Livio M; Benigni A; Zoja C; Begnis R; Morelli C; Rossini M; Garattini S; Remuzzi G
J Pharmacol Exp Ther; 1989 Jan; 248(1):334-41. PubMed ID: 2492341
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
Capone ML; Tacconelli S; Sciulli MG; Grana M; Ricciotti E; Minuz P; Di Gregorio P; Merciaro G; Patrono C; Patrignani P
Circulation; 2004 Mar; 109(12):1468-71. PubMed ID: 15037526
[TBL] [Abstract][Full Text] [Related]
3. A prostacyclin-sparing effect of indobufen vs. aspirin.
De Caterina R; Giannessi D; Bernini W; Lazzerini G; Lavezzari M; Stragliotto E; Biagi G; Coccheri S
Thromb Haemost; 1996 Mar; 75(3):510-4. PubMed ID: 8701417
[TBL] [Abstract][Full Text] [Related]
4. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.
Patrono C; Ciabattoni G; Remuzzi G; Gotti E; Bombardieri S; Di Munno O; Tartarelli G; Cinotti GA; Simonetti BM; Pierucci A
J Clin Invest; 1985 Sep; 76(3):1011-8. PubMed ID: 3900132
[TBL] [Abstract][Full Text] [Related]
5. Selectivity of oral aspirin as an inhibitor of platelet vs. vascular cyclooxygenase activity is reduced by portacaval shunt in rats.
Gambino MC; Passaghe S; Chen ZM; Bucchi F; Gori G; Latini R; de Gaetano G; Cerletti C
J Pharmacol Exp Ther; 1988 Apr; 245(1):287-90. PubMed ID: 3129553
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase inhibition with acetylsalicylic acid unmasks a role for prostacyclin in erythropoietin-induced hypertension in uremic rats.
Rodrigue ME; Lacasse-M S; Larivière R; Lebel M
Can J Physiol Pharmacol; 2005 Jun; 83(6):467-75. PubMed ID: 16049546
[TBL] [Abstract][Full Text] [Related]
7. Effect of acetylsalicylic acid, paracetamol, caffeine and a combination of these substances on the renal prostaglandin E2, 6-keto-prostaglandin F1 alpha, water, creatinine and electrolyte excretion of the rat.
Engelhardt G
Arzneimittelforschung; 1996 May; 46(5):509-12. PubMed ID: 8737637
[TBL] [Abstract][Full Text] [Related]
8. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
[TBL] [Abstract][Full Text] [Related]
9. Renal handling of aspirin in the rat.
Gaspari F; Perico N; Locatelli M; Corna D; Remuzzi G; Garattini S
J Pharmacol Exp Ther; 1989 Oct; 251(1):295-304. PubMed ID: 2507772
[TBL] [Abstract][Full Text] [Related]
10. Biochemical selectivity of oral versus intravenous aspirin in rats. Inhibition by oral aspirin of cyclooxygenase activity in platelets and presystemic but not systemic vessels.
Cerletti C; Gambino MC; Garattini S; de Gaetano G
J Clin Invest; 1986 Jul; 78(1):323-6. PubMed ID: 3088044
[TBL] [Abstract][Full Text] [Related]
11. [Effects of low dose aspirin on platelet function and prostaglandins metabolism in systemic and coronary circulation in patients with ischemia heart disease].
Liu H; Chen Z; Gao R
Zhonghua Nei Ke Za Zhi; 1995 Sep; 34(9):595-8. PubMed ID: 8697924
[TBL] [Abstract][Full Text] [Related]
12. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis.
Remuzzi G; Imberti L; Rossini M; Morelli C; Carminati C; Cattaneo GM; Bertani T
J Clin Invest; 1985 Jan; 75(1):94-101. PubMed ID: 4038407
[TBL] [Abstract][Full Text] [Related]
13. Altered renal and platelet arachidonic acid metabolism in cirrhosis.
Laffi G; La Villa G; Pinzani M; Ciabattoni G; Patrignani P; Mannelli M; Cominelli F; Gentilini P
Gastroenterology; 1986 Feb; 90(2):274-82. PubMed ID: 3079716
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of platelet thromboxane generation with low-dose aspirin does not protect rats with reduced renal mass from the development of progressive disease.
Zoja C; Benigni A; Livio M; Bergamelli A; Orisio S; Abbate M; Bertani T; Remuzzi G
Am J Pathol; 1989 May; 134(5):1027-38. PubMed ID: 2497648
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of dazoxiben, a selective thromboxane-synthase inhibitor, on platelet and renal prostaglandin-endoperoxide metabolism.
Patrignani P; Filabozzi P; Catella F; Pugliese F; Patrono C
J Pharmacol Exp Ther; 1984 Feb; 228(2):472-7. PubMed ID: 6537977
[TBL] [Abstract][Full Text] [Related]
16. Renal function and urinary prostaglandins in rats given an adenine diet.
Yokozawa T; Chung HY; Lee TW; Oura H
Nihon Jinzo Gakkai Shi; 1989 Jun; 31(6):671-5. PubMed ID: 2795996
[TBL] [Abstract][Full Text] [Related]
17. Thromboxane A2 and prostacyclin generation in the microvasculature of patients with atherosclerosis--effect of low-dose aspirin.
Kyrle PA; Minar E; Brenner B; Eichler HG; Heistinger M; Marosi L; Lechner K
Thromb Haemost; 1989 Jun; 61(3):374-7. PubMed ID: 2508252
[TBL] [Abstract][Full Text] [Related]
18. Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics.
Lianos EA; Andres GA; Dunn MJ
J Clin Invest; 1983 Oct; 72(4):1439-48. PubMed ID: 6685136
[TBL] [Abstract][Full Text] [Related]
19. Comparative effect of ibuprofen on endothelial and platelet prostaglandin synthesis.
Parks WM; Hoak JC; Czervionke RL
J Pharmacol Exp Ther; 1981 Nov; 219(2):415-9. PubMed ID: 7026767
[TBL] [Abstract][Full Text] [Related]
20. The effect of a thromboxane synthetase inhibitor, dazoxiben, and acetylsalicylic acid on platelet function and prostaglandin metabolism.
Dale J; Thaulow E; Myhre E; Parry J
Thromb Haemost; 1983 Oct; 50(3):703-6. PubMed ID: 6689091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
